Bellevue Life Sciences Acquisition (OSRH) Return on Assets (ROA) (2022 - 2026)
Bellevue Life Sciences Acquisition (OSRH) Return on Assets (ROA) from Mar 31, 2022 to Mar 31, 2026. The TTM Bellevue Life Sciences Acquisition (OSRH) Return on Assets (ROA) is -2.01%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual ROA
Quarterly ROA
Annual Return on Assets (ROA) change of Bellevue Life Sciences Acquisition (OSRH)
| Year | Return on Assets (ROA) | Change |
|---|---|---|
| 2025 | -15.80% | +1049.05% |
| 2024 | -1.38% | -225.94% |
| 2023 | 1.09% | -133.58% |
| 2022 | -3.25% | N/A |
| 2021 | 0.00% | N/A |